UP AFTER EARNINGS: Yelp (YELP), up 7%… Tecnoglass (TGLS), up 14%… Leap Therapeutics (LPTX), up 2%… Voyager Therapeutics (VYGR), up 4%. ALSO HIGHER: Symantec (SYMC), up 2% following the company’s announcement that it will sell its enterprise security business to Broadcom (AVGO) for $10.7B… Lexicon (LXRX), up 5% after announcing 52-week cardiorenal results from a pooled analysis from the inTandem1 and inTandem2 studies of Zynquista in adults with type 1 diabetes. DOWN AFTER EARNINGS: Uber (UBER), down 7%… Activision-Blizzard (ATVI), down 1%… Diplomat Pharmacy (DPLO), down 2%… U.S. Concrete (USCR), down 2%. ALSO LOWER: Nektar (NKTR), down 37% after management disclosed that the scope of collaboration with partner Bristol-Myers (BMY) is now narrowed and that there were some issues pertaining to the manufacturing of bempegaldesleukin that potentially led to the drastic difference in response rate between the November 2017 and June 2018 data announcement of the Phase II PIVOT-02 results… Amarin (AMRN), down 21% after announcing that that it received notice from the FDA that the agency plans to hold an advisory committee meeting, tentatively scheduled for November 14, in connection with its review of the pending supplemental new drug application for expansion of Vascepa labeling based on the REDUCE-IT cardiovascular outcomes study.